Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ovid Therapeutics Inc. - Common Stock
(NQ:
OVID
)
2.620
+0.320 (+13.91%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ovid Therapeutics Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Here's Why Ovid Therapeutics Stock Popped Higher Today
↗
March 18, 2026
Ovid stock surged 18% following positive Phase 1 data for OV329, and investors are getting excited about a forthcoming Phase 2.
Via
The Motley Fool
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
March 18, 2026
Via
Chartmill
Discover the top movers in Wednesday's pre-market session.
↗
March 18, 2026
Via
Chartmill
Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results
March 18, 2026
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics Announces Pricing of $60 Million Private Placement
March 18, 2026
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics to Participate in Upcoming Investor Conferences
February 25, 2026
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV)
December 18, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer
December 02, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
November 17, 2025
Via
Benzinga
OVID THERAPEUTICS INC (NASDAQ:OVID) Announces Leadership Transition and Key Pipeline Milestones Following Q3 2025 Results
↗
November 12, 2025
Ovid Therapeutics announces CEO succession plan and key pipeline progress for epilepsy drug OV329 and KCC2 activators, backed by a strong cash position.
Via
Chartmill
Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and Third Quarter 2025 Financial Results
November 12, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Curious about the stocks that are showing activity after the closing bell on Friday?
↗
October 03, 2025
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
Ovid Therapeutics Stock Rallied 18% Pre-Market – Here’s Why
↗
October 03, 2025
The company is now looking forward to initiating a mid-stage study evaluating OV329 in adult patients with drug-resistant focal onset seizures.
Via
Stocktwits
Topics
Intellectual Property
These stocks that are showing activity before the opening bell on Friday.
↗
October 03, 2025
Wondering what's happening in Friday's pre-market session? Find an overview in this article.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
October 03, 2025
Via
Benzinga
Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $175 Million in Gross Proceeds
October 03, 2025
Initial closing of approximately $81 million expected to fund current operating plan and clinical pipeline into 2028, with potential for up to $94 million in additional proceeds upon exercise of issued...
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid announces positive topline results for the next-generation GABA-aminotransferase inhibitor, OV329, that demonstrate strong inhibitory activity and a potential best-in-category safety profile
October 03, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Curious about the stocks that are showing activity after the closing bell on Tuesday?
↗
September 02, 2025
The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
August 13, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
August 13, 2025
Via
Benzinga
Top movers in Wednesday's session
↗
August 13, 2025
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
Ovid Therapeutics Reports Business Updates and Second Quarter 2025 Financial Results
August 13, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference
July 23, 2025
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Which stocks are moving after the closing bell on Tuesday?
↗
July 22, 2025
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
↗
July 21, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
July 17, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
June 27, 2025
Via
Benzinga
Get insights into the top gainers and losers of Friday's after-hours session.
↗
June 27, 2025
Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.
Via
Chartmill
Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties
June 25, 2025
Non-dilutive funding extends Ovid’s operational runway; Immedica assumes certain ganaxolone IP costs
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
Ovid Therapeutics to Host Investor and Media Event Thursday, June 12, 2025
June 05, 2025
Emerging Biomarkers in the Clinical Development of Epilepsy Medicines and OV329 Program Highlights
From
Ovid Therapeutics Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
